Close up portrait of Vanessa Malier

Vanessa Malier

Member – Kurma Partners

Ms. Malier has served as a member of our board of directors since January 2021. In 2013, Ms. Malier joined Kurma Partners, a healthcare-focused investment firm, and she has served as Managing Partner since January 2015. Prior to that, she was Vice President, R&D Strategic Planning at Ipsen Pharma, a pharmaceutical company, after having had global responsibilities for the oncology business development, for the R&D and commercial team for Adenuric, and for the gastro-enterology Franchise. Ms. Malier is a board member of Xeltis AG, Vivet Therapeutics SAS, Asceneuron AG, Step Pharma SAS as well as a board member and Chairman of Corlieve SAS. Ms. Malier was a student in Biology and Biochemistry from from ENS Paris-Saclay, received her agregation in Biochemistry and her DEA in Immunology from the Pasteur Institute.